Table 3.
Preoperative comorbidities and risk factors.
| All patients | Bone sarcoma | Soft tissue sarcoma | p value | |
|---|---|---|---|---|
| N = 1111 | N = 381 | N = 730 | ||
| n (%) | n (%) | n (%) | ||
| Functional status | ||||
| Independent | 1062 (95.6%) | 363 (95.3%) | 699 (95.8%) | 0.88 |
| Partially dependent | 40 (3.6%) | 14 (3.7%) | 26 (3.6%) | |
| Totally dependent | 3 (0.3%) | 1 (0.3%) | 2 (0.3%) | |
| Unknown | 6 (0.5%) | 3 (0.8%) | 3 (0.4%) | |
|
| ||||
| ASA classification | ||||
| ASA 1 | 47 (4.2%) | 13 (3.4%) | 34 (4.7%) | 0.738 |
| ASA 2 | 419 (37.7%) | 149 (39.1%) | 270 (37.0%) | |
| ASA 3 | 596 (53.6%) | 202 (53.0%) | 394 (54.0%) | |
| ASA 4 | 49 (4.4%) | 17 (4.5%) | 32 (4.4%) | |
|
| ||||
| Current smoker | 163 (14.7%) | 69 (18.1%) | 94 (12.9%) | 0.020 |
| Disseminated cancer | 127 (11.4%) | 58 (15.2%) | 69 (9.5%) | 0.005 |
| Diabetes | 132 (11.9%) | 35 (9.2%) | 97 (13.3%) | 0.051 |
| Preoperative wound infection | 62 (5.6%) | 12 (3.1%) | 50 (6.8%) | 0.013 |
| Dyspnea | 42 (3.8%) | 13 (3.4%) | 29 (4.0%) | 0.654 |
| Bleeding disorder | 42 (3.8%) | 8 (2.1%) | 34 (4.7%) | 0.045 |
| Preoperative transfusion | 33 (3.0%) | 12 (3.1%) | 21 (2.9%) | 0.853 |
| Steroid use for a chronic condition | 127 (2.9%) | 20 (5.2%) | 12 (1.6%) | 0.001 |
| COPD | 31 (2.8%) | 10 (2.6%) | 21 (2.9%) | >0.999 |
| Pre-op sepsis/SIRS | 31 (2.8%) | 13 (3.4%) | 18 (2.5%) | 0.443 |
| Recent weight loss | 26 (2.3%) | 9 (2.4%) | 17 (2.3%) | >0.999 |
| Congestive heart failure | 5 (0.5%) | 3 (0.8%) | 2 (0.3%) | 0.346 |
| Dialysis | 5 (0.5%) | 2 (0.5%) | 3 (0.4%) | >0.999 |
| Ventilator dependent | 1 (0.1%) | 1 (0.3%) | 0 (0.0%) | 0.343 |